The genus Aesculus L. (Hippocastanaceae) has 12 species distributed in eastern Asia, eastern and western North America, and Europe. In Europe and the United States, A. hippocastanum has been used for the treatment of chronic venous insufficiency, hemorrhoids, and postoperative edema. In China, A. chinensis var. chinense has been used as a stomachic and analgesic in the treatment of distention and pain in the chest and the abdomen, malaria, dysentery, and heart disease. The objective of this paper is to review the ethnobotany, phytochemistry, and pharmacological properties of the genus Aesculus. To date, more than 210 compounds have been isolated and identified primarily from the fruits or seeds of Aesculus, with polyhydroxylated triterpenoid saponins as the major active principles. Studies have confirmed that Aesculus seed extracts and isolates possess diverse activities, including anti-inflammatory, antitumor, antiviral, antifungal, antiangiogenic (vascular protection), anti-obesity, antioxidative, and antigenotoxic properties. Interestingly, detailed studies of the saponins from more eastern North American species and other uninvestigated Aesculus species are necessary to further confirm the chemotaxonomic value of the novel cytotoxic saponins discovered recently from A. pavia, an eastern North American species, and to fully understand the chemical profile of the genus. Animal investigations of these novel cytotoxic saponins on the potential for the treatment of cancer are also intriguing.
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INTRODUCTION
Aesculus L. is a genus of the family Hippocastanaceae containing 12 species of deciduous trees and shrubs in the northern hemisphere, primarily in eastern Asia and eastern North America, with one species native to Europe, and two to western North America [1] [2] [3] [4] . Aesculus have been cultivated as pharmaceutical crops for the production of Standardized Therapeutic Extracts (STEs). There are two Eurasian species commonly used in medicine: A. hippocastanum (common horse chestnut) and A. chinensis var. chinensis (Chinese horse chestnut). In Europe, the bark, leaves, horse chestnut seed extract (HCSE), and aescin (a saponin mixture) from A. hippocastanum have been used in the treatment of chronic venous insufficiency, hemorrhoids, and postoperative edema [5] [6] [7] [8] [9] . In China, the seeds of A. chinensis var. chinensis have been used as a stomachic and analgesic in the treatment of distention and pain in chest and abdomen, malaria, and dysentery [10] and tablets made from the seeds are also used for treating heart diseases [11] . Modern pharmacologic investigations have confirmed that HCSE, aescin and individual compounds isolated and identified from the two Eurasian species and other Aesculus species possess diverse activities, including anti-inflammatory, antitumor, antiviral, The recent phylogenetic analysis of Aesculus by DNA sequences of chloroplast gene matK and internal transcribed spacers of nuclear ribosomal RNA genes supported Hardin's classification except for section Calothyrsus [4] . Some chemotaxonomical analysis has been conducted [15] . Interestingly, A. pavia in the Section Pavia has tritepernoid saponins with an oligosaccharide chain at C-3 of the aglycone with an α-arabinofuranosyl unit affixed to C-3 of the glucuronic acid while Eurasian species in Section Aesculus and Section Calothyrsus have saponins with a trisaccharide chain at C-3 of the aglycone with a β-glucopyranosyl unit attached to C-4 of the glucuronic acid [16] (see Triterpenoid Saponins for details). This significant chemical difference suggests that triterpenoid saponins may provide important clues in understanding the systematics and evolution of the genus Aesculus.
Aesculus are deciduous trees or shrubs with easily recognizable palmately compound leaves (5-11 leaflets) , characteristic capsules and seeds, and attractive ornamental flowers. Aesculus hippocastanum has been cultivated since 1576 as an ornamental plant [17] while A. chinensis var. chinensis has been planted in temples and homes for several centuries. At present, all species are cultivated, with at least 27 commercial cultivars supplied by at least 95 nurseries in the United States [17] . Most species are propagated from seeds and the cultivars by budding or grafting. In Europe, HCSE and aescin are major pharmaceutical products from Aesculus.
Aesculus hippocastanum is a large deciduous tree, also known as Conker tree. This species is native to a small area in the mountains of the Balkans in southeast Europe, in small areas in northern Greece, Albania, the Republic of Macedonia, Serbia, and Bulgaria. It is now widely cultivated throughout the temperate world because of its large, beautiful flower clusters and its excellent resistance to environmental conditions. The leaves of this species are opposite and palmately compound with 5-7 leaflets. The sessile leaflets are green beneath with obtusely double-serrate. Its flowers are usually white with a small red spot. The fruit is a green, spiky capsule containing one (rarely two or three) brown seed, called chestnut or conker [2] .
The common name "horse chestnut″may have come from the uses of seeds for horses to treat overexertion or coughs by Turks and Greeks [18] . Dated from the early 18th century, the horse chestnut has a therapeutic property for anti-fever [5] . In Europe, the bark and leaves of A. hippocastanum have been employed as an astringent to treat diarrhea and hemorrhoids [6] . The HCSE from A. hippocastanum has been used in the treatment of chronic venous insufficiency, hemorrhoids, and postoperative edema [7] [8] [9] . Aescin, also known as β-escin, is the major active component in HCSE and has been shown to have a clinically significant activity in chronic venous insufficiency, hemorrhoids, and postoperative edema. The pharmacology, pharmacokinetics and therapeutic profile of aescin have been reviewed [5] . Based on the publication over the last two decades of numerous randomized controlled trials in prominent, peer-reviewed journals, A. hippocastanum extract is gaining wider acceptance as an effective therapy for venous disorders and edema in the United States [5] .
Aesculus chinensis is native to China and is distributed mainly in the Hebei, Henan, and Shanxi provinces. The fruits of this species usually are smooth subglobose, truncate to slightly impressed at the apex, thickly walled with smaller seeds having proportionately larger hilum. The surface of its petiolulate leaflets is glabrous or sparingly pilose [2] . Its seeds, called "Sha Luo Zhi" in traditional Chinese medicine, have long been used as a stomachic and analgesic in the treatment of distention and pain in chest and abdomen, malaria, and dysentery [10] . Additionally, the tablets made from the seeds are used for treating heart diseases [11] .
Aesculus turbinata, known as Japanese horse chestnut, is native only to Japan. It has been found on the island of Hokkaido and the central and northern parts of Honshu. This species has been widely cultured in England, the United States, and China. This species is similar to A. hippocastanum, differently mainly in the slightly smaller flowers, warty fruit surface, and in the larger leaves, which are glaucescent beneath and have more regularly crenate-serrate margins [2] . The seeds of the Japanese horse chestnut have been used as an emergency provision since ancient times and utilized traditionally in Japan as a confectionery ingredient in rice cakes and rice balls [19] . Its seed extract in combination with spirits have also been used as a folk medicine for the treatment of bruises and sprains in some regions of Japan [20] .
Aesculus indica, known as Indian horse chestnut, is found on mountain slopes or in moist and shady valleys in the northwestern Himalayan forests. It is distributed from Nepal northwestward into the State of Kashmir in north India, and across the Indus River to West Pakistan and to northeastern Afghanistan. Its fruits are reddish brown, smooth ovoids. The petiolulate leaflets of this species are submembranacous with finely serrate margin [2] . In some parts of Himachal Pradesh, the seeds are dried and grounded into flour, called tattwakhar. This flour is bitter and used for making halwa, which is taken as phalahar (non-cereal food) during fasts; the leaves are used as a fodder for cattle. India horse chestnut also has medicinal properties for animals and human beings. The fruits are given to horses suffering from colic. The oil extracted from the seeds is used to cure rheumatism [21] .
Seeds of North American species (e.g., A. pavia, A. flava, A. glabra, and A. californica), known as buckeyes, were used by Native Americans to tranquilize fish to make them easier to catch [22] . Extracts from the seeds were used to treat earaches, sores, colic, sprains, and chest pains [23] . Powdered bark was sometimes used to alleviate toothaches and ulcer pain [24] . 
PHYTOCHEMISTRY
Seeds of Aesculus are the plant materials often used for medicine in Eurasia and North America, and thus the seeds and fruits are the main targets for chemical investigations in the last several decades. To date, more than 210 compounds have been isolated and identified from Aesculus. These compounds include triterpenoids, triterpenoid glycosides (saponins), flavonoids, coumarins, carotenoids, long fatty chain compounds, and some other classes of compounds.
Triterpenoids
Triterpenoids from the genus Aesculus belong to pentacyclic triterpenoids and have multiple hydroxyl groups at C-3, C-15, C-16, C-21, C-22, C-24, and C-28. Their structures vary based on the substituents of hydroxyl at C-15 and C-24 as well as the number and type of acyl groups at C-16, C-21, C-22, and C-28. To date, six triterpenoids (1-6) and 14 acyltriterpenoids (7−20) ( Table 2) have been isolated and identified from the hydrolysate of the saponin mixtures extracted from the seeds of Aesculus. Aescigenin (1), a product of the acid hydrolysis of the saponin aescin from the seeds of A. hippocastanum, was the first triterpenoid reported [25] . Later, a number of triterpenoids (sapogenins) and acyltriterpenoids (prosapogenins) were isolated and identified from the acid and alkaline hydrolysates of the Aesculus saponin mixtures. These hydrolytic products include barringtogenol-D (2) [26] , R 1 -barrigenol (4) [27] , barringtogenol-C (6) [ [34] .
Triterpenoid Glycosides (Triterpenoid Saponins)
Triterpenoid glycosides or saponins are one of the main groups of chemical constituents from Aesculus. They are classified as polyhydroxylated triterpenoid glycosides based on four different aglycones (sapogenins), including 24hydroxy-R 1 -barrigenol (3), R 1 -barrigenol (4), protoaescigenin (5), and barringtogenol-C (6), due to the different substituents of hydroxyl at C-15 and C-24. To date, about 79 saponins have been isolated and identified from the genus Aesculus ( Table 2 ). Most of the Aesculus saponins have a trisaccharide chain with a glucuronopyranosyl unit attached to the C-3 position of the aglycone. A few saponins have a disaccharide chain at C-3 of the sapogenin, such as assamicins V (69), VIII (71), aesculiosides Ie (76), and IId (80) while assamicins II (68), III (60), IV (61), and VI (62) are bisdesmosidic glycosides. The Aesculus type of saponins usually possesses acyl functions at C-21, C-22, and C-28 positions, some rarely, at C-16, such as escin VIb (36) . The acyl functions include angeloyl (Ang), tigloyl (Tig), acetyl (Ac), 2-methylbutanoyl (MB), and 2-methylpropanoyl (MP) groups.
The isolation and the structural determination of the individual ingredients in the saponin mixtures from the genus Aesculus have been the target of many investigations. The structures of two major saponins in aescin from the seeds of A. hippocastanum were first presumed as escins Ia (21) and Ib (22) on the basis of chemical and physicochemical evidences obtained by using the saponin mixture [26, 35] . Then, the two major saponins were isolated from the commercial β-escin [36] , and their MS data were reported based on the previous presumed structures [37] . The detailed phytochemical investigation of the saponins from A. hippocastanum was conducted by Yoshikawa's group [38] [39] [40] . A total of 12 saponins were isolated from the seeds of this species. The structures of these saponins were determined by extensive NMR and HRMS analysis as well as chemical degradation. These saponins are escins Ia (21) [38, 39] , Ib (22) [38, 39] , IIa (23) [38, 39] , IIb (24) [38, 39] , IIIa (25) [38, 39] , IIIb (26) [40] , IV (27) [40] , V (34) [40] , and VI (35) [40] and isoescins Ia (43) [40] , Ib (44) [40] , and V (49) [40] .
The seeds of A. turbinata also contain rich triterpenoid saponins as the main components. A number of investigations on the seeds of Japanese horse chestnut resulted in the isolation and structure determination of 16 polyhydroxylated triterpenoid saponins. These saponins are escins Ia (21) [41] , Ib (22) [41] , IIa (23) [42] , and IIb (24) [42] ; deacetylescins Ia (37), Ib (38) , IIa (39) , and IIb (40) [43] ; desacylescins I (41) and II (42) [43] ; escin IVc (28) [44] ; isoescin Ia (43) [44] , Ib (44) [44] , VIa (50) [45] , VIIa (51) [45] , and VIIIa (52) [45] .
Of the section Calothyrsus, A. chinensis var. chinensis has been well investigated. The triterpenoid saponins, occurring as a complex mixture in the seeds of A. chinensis var. chinensis, had not been investigated until 1999, when two groups of researchers reported a number of novel saponins. The first group reported four pair of new geometrical isomer saponins from the plant, named aesculiosides A-H (53-56, 63-66), with two pair of known compounds, escins Ia (21), and Ib (22) and isoescins Ia (43) and Ib (44) [46] . The second group reported four new saponins escins IVc (28), IVd (29) , IVe (30) , and IVf (31) [47] . The structures of these novel saponins were determined by extensive NMR, HRMS, and x-ray analyses, as well as chemical degradation. Later, from 2001 to 2004, more Aesculus polyhydroxylated triterpenoid saponins were isolated and identified from the seeds of A. chinensis var. chinensis. These saponins include escins IVg (32), IVh (33) , and VIb (36) [48] ; desacylescin I (41) [48] ; isoescins IIa (45), IIb (46), IIIa (47) , and IIIb (48) [49] ; and aesculiside A (58) [50] . Escins Ia (21) , Ib (22) , IIIa (25), isoescins Ia (43), Ib (44), IIa (45), IIb (46) , and IIIa (47) were isolated and identified from A. chinensis var. wilsonii [51] . Aesculus chinensis Bunge var. chekiangensis (Hu & W.P. Fang) W.P. Fang was described based on cultivated plants and is now recognized as the synonym of A. chinensis var. wilsonii [14] . Its seeds, also called "Sha Luo Zhi" in The saponins from other species of the section Calothyrsus were also reported. Interestingly, some unique saponins including assamicins I (67) [54] , II (68) [54] , III (60) [55] , IV (61) [55] , V (69) [56] , VI (62) [57] , VII (70) [57] , and VIII (71) [57] were isolated and identified from A. assamica, together with a known saponin isoescin Ib (44) . In addition, aesculusides A (deacetylescin Ib, 38) [58] , B (59) [59] , and
The investigation of saponins from section Pavia is limited to A. pavia. Recently, a detailed phytochemical investigation of the saponins occurring as a very complex mixture from the fruits of A. pavia located in Nacogdoches (Texas, USA) resulted in the isolation and discovery of 25 
The polyhydroxylated triterpenoid saponins from the genus Aesculus share a common oligosaccharide chain with a glucuronopyranosyl unit attached to C-3 of the aglycone, although the components and sequences of the oligosaccharides are different, Interestingly the type of the monosaccharide linked to C-2 of the glucuronopyranosyl unit in the oligosaccharide chain for the most of saponins (21-50, 53-68) is related to the substituent at C-24 of aglycone. Specifically, the saponins possessed the aglycones of 24-hydroxy-R 1barrigenol (3) or protoaescigenin (5) with a hydroxyl group at C-24 had a glucopyranosyl or xylopyranosyl unit attached to C-2 of the glucuronopyranosyl unit while a galactopyranosyl unit linked to C-2 of the glucuronopyranosyl unit was found in the saponins with the aglycones of R 1barrigenol (4) or barringtogenol-C (6) without the hydroxyl group at C-24. Isoescins VIIa (51) Table  2) , were structurally based on two aglycones of protoaescigenin (5) and barringtogenol-C (6) with a trisaccharide chain at C-3 position of the aglycone. This trisaccharide chain has a glucopyranosyl unit attached to C-4 of the glucuronopyranosyl unit, which is linked to C-3 of the aglycone. The aglycones of the saponins from the North America species A. pavia are more variable with four different aglycones, in-cluding 24-hydroxy-R 1 -barrigenol (3), R 1 -barrigenol-C (4), protoaescigenin (5) and barringtogenol-C (6). These saponins (72-99) from A. pavia have an oligosaccharide chain at C-3 of the aglycone with an arabinofuranosyl unit affixed to C-3 of the glucuronopyranosyl unit instead. This significant chemical difference represents a variable chemotaxonomic feature and may be the basis for different medicinal uses between North American and Eurasian Aesculus species. This result also supports a conclusion drawn from phenotypic and DNA sequence analyses that eastern North American species of Aesculus represent a different evolutionary lineage that diverged early from their Eurasian counterparts [1, 4, 13] .
It is also worth mentioning that assamicins I (67), II (68), III (60), IV (61), V (69), VI (62), VII (70) , and VIII (71) from A. assamica have different components and sequences of the oligosaccharide chain at C-3 from the saponins isolated from the other Aesculus species. Some of assamicin saponins (60, 61, 62, and 68) have two oligosaccharide moieties attached to C-3 and C-21 of the aglycone.
Flavonoids
Flavonoids and their derivatives are also one of the main components of the genus Aesculus. A total of 49 flavonoids including flavonols and their glycosides (100-126), flavanones, and flavanone derivatives (127-148) were isolated and identified from the seeds of Aesculus. The glycosides of quercetin (100) and kaempferal (116) with an oligosaccharide chain at C-3 or two oligosaccharide chains at C-3 and C-3' are types of flavonol glycosides while flavanone derivatives are characterized as one of two types of proanthocyanidin and polymerized epicatechin.
A few early investigations led to the isolation and identification of rutin (111), quercitrin (113), and astragalin (122) from A. indica [62, 63] and quercetin (100) and kaempferal (116) from A. assamica [33] .
The flavonols and their glycosides from the seeds of A. hippocastanum have been well documented. Two investigations on the seeds of this species resulted in the isolation and structural determination of 15 flavonols and their glycosides [64, 65] . These compounds are quercetin 3 [69] , and leucocyanidine (128) [70] from the seeds of A. hippocastanum; and three docyl sulfide derivatives of (−)-epicatechin (129) and proanthocyanidins (147, 148) from the seeds of A. turbinata [19] .
Coumarins
Coumarins isolated from Aesculus usually have simple structures. The main coumarins are esculetin (150), fraxetin (151), fraxin (156), and aesculin (157) from A. turbinata [71, 72] ; umbelliferone (149), esculetin (150), scopoletin (152), isoscopoletin (153), skimin (154), chikhorin (155), fraxin (156), aesculin (157), scopolin (158), and isoscopolin (159) from A. hippocastanum [73] ; and scopolin (158) and 5methoxyscopolin (160) from A. pavia [61] . Recently, a new prenylated coumarin with antifungal activity, pavietin (161), was isolated and identified from the leaves of A. pavia [67] .
Carotenoids
Twenty-one carotenoids have been identified from Aesculus. An early investigation on the leaves and pollen of the three species A. turbinata, A. pavia, and A. parviflora by HPLC analysis indicated the presence of seven carotenoids β-carotene (162), zeaxanthin (163), α-carotene (167), lutein (168), capsanthin (176), capsanthin 5,6-epoxide (177), and capsorubin (178) [74] . A high concentration of α-carotene was found in the leaves and keto hydroxyl carotenoids with a pentanuclear ring structure (capsanthin, capsanthin 5,6epoxide, and capsorubin) were identified in the pollen. These keto hydroxyl carotenoids were proposed to have special chemotaxonomic significance for the genus Aesculus. Later, in 2000, 16 carotene derivatives were detected in buds, pollen, and petals of A. hippocastanum and A. pavia by HPLC analysis with a diode array detector utilizing authentic samples as the references. These carotenoids are β-carotene (162), β-cryptoxanthin (164), violaxanthin (165), 9-cis- [75] .
Long Fatty Chain Compounds
The seeds of Aesculus also contain a number of long fatty chain compounds. These compounds include lauric acid (183), myristic acid (184), palmitic acid (185), stearic acid (189), arachic acid (190), and oleic acid (191) from A. hippocastanum and A. indica [76] ; linoleic acid (192) from A. hippocastanum [70] ; oleic acid (191), linoleic acid (192), and linolenic acid (193) from the seeds of A. turbinata [20] ; heptadecanoic acid (186), methyl heptadecanoate (187), ethyl heptadecanoate (188), methyl octadec-(13Z)-enoate (194), ethyl octadec-(13Z)-enoate (195) [77] , palmitone (197), n-hentriacontanol (198), and n-hentriacontane (199) from A. indica [78] ; and tianshic acid (196) from A. chinensis var. wilsonii [79] .
Other Compounds
Some other classes of components were isolated and identified from some species of Aesculus. These compounds are ester of indole-3-acetic acid and myo-inositol (200), ester of indole-3-acetic acid and the disaccharide rutinose (201), three cyclopropane amino acids of cis-α-(carboxycyclopropyl)-glycine (202), trans-α-(carboxycyclopropyl)-glycine (203), and exo-3,4-methanoproline (204) from A. parviflora [80, 81] ; 2-amino-4-methylhexanoic acid (205), 2-amino-4methylhex-4-enoic acid (206), N-(1-carboxy-3-methyl-3pentenyl-glutamine (207), α-amino-β-methyl-2-methylenecyclopropanepropionic acid (208), 2-amino-6-hydroxy-4methylhex-4-enoic acid (209), and arbutin (210) from A. californica [68, 82] ; and wilsonic acid (211), N-acetyl glutamic acid (212), and fumaric acid (213) from A. chinensis var. wilsonii [79, 83] .
BIOLOGICAL AND PHARMACOLOGICAL ACTIVI-TIES

Anti-inflammatory Activities
The therapeutic benefits of HCSE and aescin for the treatment of chronic venous insufficiency, hemorrhoids, and postoperative edema are due to their significant antiinflammatory properties, which were demonstrated in animal models [5, 50, 84, 85] . The anti-inflammatory activities of HCSE or aescin are related to the molecular mechanism of the agents, which include the improved entry of ions into channels [86] thus raising venous tension [87] , the release of prostaglandin-F2a from veins [88] , the release of inflamma-tory mediators by decreasing leukocyte activation and adhesiveness [84, 89] , the antagonism to the pro-inflammatory 5-HT receptors and histamine [90] , and the decrease in the activity of tissue hyaluronidase [91] .
Individual compounds isolated and identified from the genus Aesculus also showed anti-inflammatory properties. Escins Ia (21) , Ib (22) , IIa (23), and IIb (24) from A. hippocastanum prevented the increase of vascular permeability induced by both acetic acid in mice and histamine in acute inflammatory rats. Escins Ia, Ib, IIa, and IIb inhibited hind paw edema induced by carrageenin and scratching behavior in mice. However, desacylescins I (41) and II (42) without acyl groups had no effects in the animal model tested, which suggests that acyl groups in escins were essential for their activities [92] . Escins Ia, Ib, isoescins Ia (43) , and Ib (44) isolated from the seeds of A. chinensis var. chinensis markedly inhibited dimethyl benzene induced inflammation in mice at a dose of 30 mg/kg. The inhibitory effects of the four pure saponins were nearly equal to each other, but had more potent activity than a total saponin extract and dexamethasone, a commercially available anti-inflammatory drug [50] . Oleic acid (191), linoleic acid (192), and linolenic acid (193) from a hexane seed extract of A. turbinata showed an inhibition of the activity of cyclooxygenase (COX-1 and COX-2), the important target for anti-inflammatory drugs. Linolenic acid and linoleic acid had a high selectivity toward COX-2 [20] .
Anti-tumor Activities
Recent studies in vivo and in vitro indicate that aescin (βescin) has significant antitumor activities. β-escin from A. hippocastanum inhibited chemically induced colon carcinogenesis in rats, and in vitro exhibited cytotoxicity at 30 β-escin isolated from the seeds of A. chinensis var. chinensis induced apoptosis and caused a significant inhibition of HL-60 human acute myeloid leukemia cell and K562huamn chronic myeloid leukemia cell proliferation in doseand time-dependent fasion. Morphological evidence of apoptosis, a significant increase of annexin V+ and PI-cells (early apoptotic) and apoptotic DNA fragmentation, were observed in K562 cells treated with β-escin. Flow cytometry analysis indicated that β-escin induced G 1 -S arrest and led to a significant accumulation of the sub-G 1 population in HL-60 and K562 cells [94, 95] .
Aescin isolated from the seeds of A. chinensis var. wilsonii at a dose of 2.8 mg/kg had a rather high inhibition ratio (43.5 %) on mice H22 tumor growth in vivo. Aescin could induce significant concentration-and time-dependent inhibition of HepG (2) cell viability and induce cell cycle checkpoint arrest and caspase-independent cell death in HepG (2) cells [96] .
An early investigation showed that two prosapogenins of 21-O-tigloyl-22-O-angeloyl-R 1 -barrigenol (10) and 21-Oangeloylbarringtogenol-C (18) from the acid hydrolysates of the HCSE of A. hippocastanum exhibited significant in vitro cytotoxicity with ED 50 of 3.6 µg/mL and 3.0 µg/mL, respectively, in the human nasopharyngeal carcinoma 9-KB cell culture assay [27] .
More recently, 28 individual saponins from the fruits of A. pavia and six prosapogenins produced from these saponins were assayed in vitro for their cytotoxicity and inhibition of DNA topoisomerase I (TOP1) [61, 97] . Saponins 94, 96 and 98 with two acyl groups at C-21 and C-22 showed activity with GI 50 of 0.175-8.71 µM against most of 59 cell lines tested, which were from nine different human cancers including leukemia, non-small cell lung, colon, central nervous system (CNS), melanoma, ovarian, renal, prostate, and breast tumor cell lines. Aesculiosides IIc (79) and
IId (80) with only one acyl group at C-21 showed less activity while aesculiosides Ia-e (72-76) without acyl group showed no or weak activity [61] . Aesculiosides IIa-k (77) (78) (79) (80) (81) (82) (83) (84) (85) (86) (87) , IIIa-f (88) (89) (90) (91) (92) (93) , IVa (95) respectively, showed no TOP1 inhibitory activity, but had stronger cytotoxicity when compared to the related saponins [97] .
Antiviral and Antifungal Activities
Isoescins Ia (43) and Ib (44) and escins Ia (21) , Ib (22) , IVc (28) , IVd (29) , IVe (30) , and IVf (31) isolated from the seeds of A. chinensis var. chinensis showed activity against HIV-1 protease. Escins Ia (21) and Ib (22) inhibited the enzyme's activity by 86.1 ± 0.2% at 100 µM with IC 50 values of 35 and 50 µM, respectively, while saponins 28-31, 43, and 44 showed weaker antiviral activity [47] .
Three flavonol glycosides of aescuflavoside (103), aescuflavoside A (105), and leucoside (120) from A. chinensis var. chinensis showed significant antiviral activities against respiratory syncytial virus with IC 50 values of 4.5, 6.7, and 4.1 µg/mL, and selective index values of 15.8, 32, and 63.8, respectively. Astragalin (122) demonstrated significant antiviral activity against influenza virus type A with an IC 50 of 24.5 µg/mL and a selective index of 16.0 [66] .
Pavietin (161), a new prenylated coumarin, isolated from the leaves of a genotype of A. pavia, showed antifungal activity. In a preliminary antifungal screening by filter disk method, pavietin (15 mg/dish) possessed significant activity against an Aesculus-specific fungal parasite, Guignardia aesculi, and weaker activity against the generalist polyphagous Pythium ultimum and the Aesculus nonpathogenic Fusarium basilici. More detailed antifungal screening by adding pavietin to mycelial growth medium of different fungal pathogens showed that pavietin exhibits appreciable antimicrobial properties against several pathogens including Alternaria alternata, A. dianthi, Aspergillus niger, Botrytis cinerea, Cladosporium fulvum, Fusarium oxysporum dianthi, Guignardia aesculi, Penicillium expansum, Polyporus marginatus, Rhizopus stolonifer, and Trichoderma viride [67] .
Antiangiogenic Activities (Vascular Protection)
β-escin sodium inhibited angiogenesis in chick chorioallantoic membrane [98] and in aortic disk assay [99] . Further study indicated that β-escin sodium (10, 20, and 40 µg/mL) dose-dependently inhibited endothelial cells (ECs) proliferation in human umbilical vein endothelial cells and ECV304 cells. β-escin sodium also induced ECs apoptosis at 40 µg/mL and suppressed ECs migration and cell motility. Western blot results suggest that β-escin sodium acts on ECs possibly by increasing expression of thrombospondin-1, decreasing expression of PKC-α and activation of p44/42 mitogen-activated protein (MAP) kinase and p38 mitogenactivated protein kinase (p38 MAPK) [100] .
Aescin from A. hippocastanum was found to improve endothelial dysfunction in rat aortic rings subjected to oxidative stress generated by pyrogallol and to induce contraction in these preparations. These apparently contradicting effects could be due to the well-known ability of escin to enhance cellular permeability to calcium which, on one hand, would increase endothelial nitric-oxide synthase (eNOS) activity and nitric oxide production and would lead to vascular smooth muscle contraction. Endothelial protection could contribute to the therapeutic usefulness of escin, while arterial vasoconstriction could represent a limiting side effect in susceptible patients [101] .
When HUVECs (human vascular endothelial cells) were exposed to CoCl 2 as an in vitro model of hypoxia, aescin from A. hippocastanum, in a dose-dependent fashion (0.1-1.0 µM), prevented the action of CoCl 2 on the vascular cell adhesion molecule (VCAM-1) and platelet endothelial cell adhesion molecule (PECAM-1) and preserved endothelial cell morphology. In an in vitro model of inflammation induced by Escherichia coli lipopolysaccaride (LPS), aescin reduced IL-6 release from LPS-activated vascular endothelium [102] . HCSE from A. hippocastanum dose-dependently contracted both bovine mesenteric veins and arteries, with veins being the more sensitive. Contraction of both veins and arteries was significantly inhibited by the 5-HT(2A) receptor antagonist ketanserin. HCSE also significantly reduced ADPinduced human platelet aggregation. These findings may, at least partly, account for the mechanism of action of HCSE in the treatment of chronic venous insufficiency [103] .
Anti-obesity Effects
Escins Ia (21) , Ib (22) , IIa (23), IIb (24), deacetylescins Ia (37), Ib (38), IIa (39), IIb (40), and desacylescins I (41) and II (42) had inhibitory effects on the elevation of blood glucose levels by means of the oral glucose tolerance test in mice. Escins (21) (22) (23) (24) with two acyl groups had stronger activity than deacetylescins (37-40) with only one acyl group and desacylescins (41, 42) without acyl group [38, 39, 43] . These compounds also exhibited the activity of pancreatic lipase with very different IC 50 values. Escins (21-24) had low IC 50 values of 14−61 µg/mL, while deacetylescins Ia and IIa had very high IC 50 values of 345, and >400 µg/mL, respectively [43] . Escins (21) (22) (23) (24) with two acyl groups at C-21 and C-22 showed potent inhibitory activity on ethanol absorption in the dose of 50-100 mg/kg [38, 39] . An analysis comparing the structure and activity suggested that the acyl groups at C-21 and C-22 in these saponins were important for their activities.
Testing by using 4-methylumbelliferyl oleate as a substrate, escins (21) (22) (23) (24) , deacetylescins (37) (38) (39) (40) , and desacylescins (41, 42) isolated from the natural and edible seeds of A. turbinata exhibited inhibitory effect on lipase activity. The potency was in the order of escins > desacylescins > deacetylescins. Escins Ib and IIb as well as deacetylescins Ib and IIb with the angeloyl moiety were more potent than the corresponding Ia and IIa series with the tigloyl moiety. Saponin fractions from natural seeds (SFNS) and edible seeds (SFES) of A. turbinata effectively inhibited fat digestion in an in vivo anti-obesity experiment in mice fed highfat diets. SFNS (0.1% or 0.5%) and SFES (0.5%) both significantly attenuated the elevation in body weight, the mass of peritoneal adipose tissues, and plasma triacylglycerol, which was accompanied by higher contents of undigested fats in feces without changes in food intake [104] . Escins Ib and IIa also inhibited pancreatic lipase activity with dosedependence (0-0.5 mg/mL) in an in vitro assay system using triolein emulsified with lecithin [105] .
In addition, assamicins I (67, 100 µg/mL) and II (68, 25 µg/mL) almost completely inhibited release of free fatty acids from epinephrine-treated rat adipocytes. Both compounds enhanced glucose uptake into 3T3-L1 adipocytes as insulin does. When the cells were incubated in a medium containing [3H]-2-deoxyglucose, the uptake of the radioisotope into the cells was enhanced 2.5-and 3.5-fold by addition of assamicins I and II, respectively, at the concentration of 25 µg/mL. Assamicin II showed stronger activity than assamicin I in both assay systems tested [57] .
Antioxidant and Antigenotoxic Activities
HCSE from the seeds of A. turbinata dose-dependently inhibited the autooxidation of linoleic acid (IC 50 of 0.2 mg/mL) and the inhibition was almost complete at a concentration of 1 mg/mL. The HCSE scavenged DPPH radicals and superoxide anions with IC 50 of 0.65 and 0.21 mg/mL, respectively. The polyphenols (21 mg/g) in the HCSE were the main active compounds [106] . This HCSE also inhibited the genotoxicities induced by furylfuramide, N-methyl-Nnitrosourea, methyl methanesulfonate, mitomycin C, 2aminoanthracene and aflatoxin B 1 at a concentration of 1 mg/mL or more [106] .
Aescin from the seeds of A. hippocastanum increased the antioxidative defense system of the body and prevented high fat diet (HFD)-induced lipid peroxidation in male mice fed either standard pellet diet (SPD) or HFD at 100mg/kg doses daily for 5 weeks. Aescin mixture prohibited the adverse effects of oxidative stress and showed a protective effect on the liver architecture both in SPD and HFD consumed male mice. Combined administration of high-fat diet with escin mixture significantly increased blood and liver reduced glutathione GSH levels in mice and decreased the level of malondialdehyde in blood, liver, kidney, heart, the level of liver superoxide dismutase, and the catalase activity [107] .
Three docyl sulfide derivatives of (−)-epicatechin (129) and proanthocyanidins (147, 148) isolated from the seeds of A. turbinata showed potent antioxidative activity by assaying with DPPH (1,1-diphenyl-2-picrylhydrazyl). Compounds 147 and 148 exhibited similar antioxidative activities with IC 50 of 2.4−2.6 µg/mL. Their inhibitory actions were slightly more potent than that of the monomer of (−)-epicatechin or (+)-catechin [19] .
CONCLUSIONS
The genus Aesculus has 12 species, but only A. hippocastanum and A. chinensis var. chinensis, two Eurasian species, are officially recognized sources of herbal products in traditional medicine. HCSE or aescin from A. hippocastanum has shown satisfactory evidence for clinically significant activity in chronic venous insufficiency, hemorrhoids, and postoperative oedema, largely due to its anti-inflammatory properties, which were well demonstrated by in vitro and in vivo assay. However, the mechanism of action of the Chinese horse chestnut is poorly understood and further investigation is necessary.
Although other constituents may have some bioactivity, the polyhydroxylated triterpenoid glycosides (saponins) in Aesculus extract are considered to be the major active principles. To date, the saponins from the seeds of six species including A. hippocastanum (AH), A. chinensis var. chinensis (ACC), A. chinensis var. wilsonii (ACW), A. turbinata (AT), A. assamica (AA), and A. pavia (AP) have been well documented. Very interestingly, the saponins from four Eurasian species (AH, ACC, ACW, and AT) have very similar structures but are different from the novel cytotoxic saponins from an eastern North American species A. pavia. This chemical difference suggests a chemotaxonomic significance between the two groups [13, 61] .
More studies of the saponins from the seeds of other North American species are necessary to further confirm the chemotaxonomic value of these novel cytotoxic saponins. Detailed investigations on the saponins from the seeds of other Aesculus species, which have not been conducted phytochemically, are also needed to fully understand the chemical profile of the genus Aesculus. These studies, which are now being conducted at Stephen F. Austin State University, may not only identify more bioactive saponins but could also provide chemotaxonomic data for the genus Aesculus and better understanding of its evolution.
The biological and pharmacological activities of HCSE, aescin, and individual components from the genus Aesculus have received much interest in recent years. Accumulated studies indicate that HCSE, aescin, and individual compounds have anti-inflammatory, antitumor, antiviral, antifungal, antiangiogenic (vascular protection), anti-obesity antioxidative, and antigenotoxic properties. One of the most interesting activities is the antitumor property of some novel saponins discovered recently from A. pavia. This type of novel saponins has showed potent cytotoxicity and inhibition of TOP1 by in vitro assays [61, 97, 108] . Further animal studies are required to evaluate the potential for the treatment of cancer as anticancer agents. 
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